Resolute Advisors LLC Johnson & Johnson Transaction History

Resolute Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$158.14 - $179.59 $195,777 - $222,332	-1,238 Reduced 99.52%	6 $1,000
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $109,774 - $121,799	-704 Reduced 36.14%	1,244 $213,000
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $87,533 - $97,272	-542 Reduced 21.77%	1,948 $315,000
Q2 2021 Dec 27, 2021	BUY	$159.48 - $171.07 $159 - $171	1 Added 0.04%	2,490 $410,000
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $282,598 - $303,136	1,772 Added 247.14%	2,489 $410,000
Q1 2021 Dec 27, 2021	BUY	$153.07 - $170.48 $109,751 - $122,234	717 New	717 $83,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Resolute Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Resolute Advisors LLC with notifications on news.